$1.03 0.03 (+2.99%)
2/13/2012 10:03 AM

StemCells, Inc. (NASDAQ:STEM)

CAPS Rating: 2 out of 5

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

Featured Broker Partners


Advertisement